Recent Tech Transfer Deals, April 2012
This article was originally published in Start Up
START-UP ’s monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions—in in vitro diagnostics, pharmaceuticals, research/analytical equipment & supplies, and medical devices.
You may also be interested in...
Gene therapy dominated the top December deals, with a $2.9bn alliance between Roche and Saretpta for DMD treatment SRP9001, and Astellas's $3bn acquisition of Audentes Therapeutics. Follow-on public offerings made up close to or more than half of both biopharma and device financing.
Recent venture funding for emerging biopharma companies, including CF PharmTech, Codagenix, Empirico, Epirium, Generation, Kyverna, NorthSea, VectivBio, Rig and Tarsus.
A review of biopharma start-up dealmaking and financing activity from October through December 2019, based on data from Strategic Transactions, showed a large rise in fundraising transactions from Q3 to Q4 of last year.